NasdaqGS:VRTXBiotechs
A Look At Vertex Pharmaceuticals (VRTX) Valuation After Recent Share Price Choppiness
Recent Share Performance Snapshot
Vertex Pharmaceuticals (VRTX) has attracted attention after a mixed stretch for the stock, with a small 1 day gain, pressure over the past week and month, and a positive past 3 months and 1 year track record.
Against that backdrop, investors are weighing how the company’s US$12,001.3m in revenue, US$3,953.2m in net income and current share price of US$460.87 fit with its longer term total returns and perceived valuation.
See our latest analysis for Vertex...